SUMMA
The effects of coronary arterial perfusion with a perfluorochemical substance (perfluorotributylamine) on the segmental myocardium of the beating heart were studied in 12 open chest anesthetized dogs. Following 10min of left anterior descending coronary artery occlusion, perfusion of the coronary artery with the perfluorochemical returned myocardial function and metabolism toward control states, although myocardial diastolic properties as well as coronary venous PCO2 and lactate were not restored completely within 7min after reperfusion. Perfluorochemicals may be of clinical importance in protecting the ischemic myocardium because of their oxygen carrying capacity together with favorable physicochemical properties for protection of the microcirculation. gauges (Nihon Koden, TH 602-T) were sutured in the ischemic and nonischemic myocardium to monitor changes in segment length (myocardial contraction was expressed as percent shortening, i.e., shortening ratio to enddiastolic fiber length). Electrodes were also sutured in the ischemic and nonischemic areas to record the local electrocardiogram (Fig.1) . All measurements were recorded at paper speeds of 50mm/sec and 200mm/sec (Fig.  2) .
As an index of myocardial contractility, myocardial contractile element shortening velocity (maxVce) was calculated from the left ventricular pressure and dP/dt curves.15) As an index representing myocardial relaxation, time constant T was calculated according to Weiss et al16) from the left ventricular pressure and dP/dt curves. The overall frequency response of the pressure recording system using the short large bore cannula was 100Hz, which appears to allow measurements of the above indices with permissible ranges of error.
Collaterals seen between the left anterior descending coronary artery for paired comparison and considered significant when p<0.05. Measurements before and during coronary occlusion and reperfusion with the perfluorochemical are shown in Table II . Heart rate, left ventricular end-diastolic pressure and time constant T increased significantly during coronary occlusion compared to the control state. There were significant decreases compared to the control values in left ventricular systolic pressure, systolic dP/dt, diastolic dP/dt, aortic flow, maxVce and the contraction of the ischemic myocardium. The ST-segment of the ischemic myocardium was significantly elevated during coronary occlusion but there was no significant change in the nonischemic area. There were no significant changes in the gas analyses or lactate levels of the systemic arterial blood during coronary occlusion, whereas there were significant elevations in lactate and PCO2 levels and a significant decline in the pH of coronary venous blood. During coronary arterial perfluorochemical perfusion, these abnormalities improved toward control values.
However, there were still significant elevations compared to the control values in left ventricular end-diastolic pressure, time constant T, ST segment elevation, coronary venous lactate and Pco,. Heart rate was significantly reduced, while left ventricular systolic pressure and coronary venous Pot were significantly elevated as compared to the control values.
Measurements before, during coronary occlusion and at release of the coronary occlusion are shown in Table III (Group B) . Heart rate, left ventricular end-diastolic pressure and time constant T increased significantly during coronary occlusion compared to the control state. There were significant decreases compared to the control values in left ventricular systolic pressure, systolic dP/dt, diastolic dP/dt, aortic flow, maxVce and the contraction of the ischemic myocardium. The ST-segment of the ischemic myocardium was elevated significantly during coronary occlusion and there was no significant change in the gas analyses and lactate levels of the systemic arterial blood during coronary artery occlusion, whereas there were significant elevations in lactate and PCO2 and significant declines in pH and Pot levels of coronary venous blood.
During reoxygenation of the ischemic myocardium following release of the coronary artery, these abnormalities improved toward control values. However, there were still significant elevations in the ST-segment of the ischemic area and the lactate level of the coronary venous blood, whereas there were no significant elevations in left ventricular end-diastolic pressure and left ventricular diastolic time constant T as were encountered in Group A.
There was a significant residual increase in heart rate during reperfusion, while arterial PCO2 was significantly reduced and coronary venous pH significantly increased during reperfusion.
There was no abnormal deposition of perfluorochemical (vacuoles)4) or significant ischemic change observed by light microscopic examinations.
DISCUSSI
Rousou et al11) have demonstrated that Fluosol DA cardioplegia preserved myocardial adenosine triphosphate and creatine phosphate during experimental cardiopulmonary bypass of 2 hours duration, although myocardial contractility (maxVce) and myocardial compliance did not completely recover following cardiopulmonary bypass in the in situ pig heart model. Kanter et al10) have shown that oxygenated perfluorochemical (Fluosol 43) cardioplegia during global ischemia of the isolated rabbit heart was superior to blood cardioplegia in improving myocardial oxygen consumption, developed pres-Jpn. Heart M arch 85 sure, maximal dP/dt and end-diastolic pressure, though the failure with blood cardioplegia was estimated to have resulted partly from a leftward shift of the oxygen-hemoglobin dissociation curve under hypothermic conditions. Itaoka et al14) have demonstrated that angiographic contrast material mixed with perfluorochemicals infused into the left anterior descending coronary artery induced less reduction in myocardial function than did conventional methods. However, there has been no attempt to investigate the pure effects of perfluorochemicals on the myocardium of the in situ beating heart. In the present study, perfusion of the segmental ischemic myocardium induced by coronary occlusion of 10min duration (Group A) resulted in the restoration of the myocardial contraction with incomplete recovery of left ventricular enddiastolic pressure, time constant T, localized ST segment elevation, coronary venous lactate and PCO2.
On the other hand, even with reperfusion with coronary artery blood after 10min of coronary occlusion, ST elevation and coronary venous lactate were not improved to the control levels. Jennings et al18) detected initial histological abnormalities in the canine posterior papillary muscle after more than 19min of coronary ligation. The paucity of collaterals in the posterior papillary muscle appears to explain the reduced time needed to induce irreversible myocardial morphology by ischemia. In addition, in this study, visible epicardial collaterals were ligated preceding the initiation of each experiment. On the other hand, Puri et al19) and Banka et al20) have indicated that myocardial contractility and metabolism were promptly improved following myocardial reperfusion after 45min of coronary occlusion. However, Heyndrickx et al21) have reported that a 15min period of coronary occlusion resulted in impairment of myocardial function and Reimer et al22) have reported that reduction in adenosine triphosphate induced by coronary artery occlusion of 15min duration needs more than 96 hours to be completely normalized. Therefore, the persistance of several abnormal functional or metabolic parameters might have been inevitable in the experimental procedures which were used in the present study. Still, the grade of abnormalities in coronary venous lactate and ST segment elevation as well as the diastolic disorders were apparently more marked in Group A. The capacity for fluorochemicals to transport carbon dioxide is lower than that of the whole blood.8) Although Rude et al12) have shown that the rise of intramyocardial PCO2 in the ischemic canine myocardium was significantly reduced by systemic perfusion with fluorochemicals (mixture of 60% perfluorodecalin and 40% perfluorotributylamine), the present study revealed the lack of CO2 transport capacity of the perfluorochemical.
Perfluorochemicals are not completely similar to whole blood in their composition and are devoid of catecholamines. The perfluorochemical was infused at the rate of 1.6ml/Kg/min, which was almost compatible with the LAD flow at the level of the second diagonal branch measured in our laboratory in another series of dogs, though the perfluorochemical was not infused as a pulsatile flow but as a steady flow. The fall in heart rate during perfluorochemical administration as observed in this study has been reported during perfluorochemical infusion with or without oxygen administration.12) With regard to increased left ventricular pressures seen during perfluorochemical coronary perfusion, the possibility that the perfluorochemical might have penetrated into the systemic circulation resulting in volume overloading should be ruled out. However, aortic flow was not significantly augmented and the white perfluorochemical substance would be easily observed penetrating into the circumferential or right coronary arteries via the collaterals if patent. Engelman et al9) have reported augmented myocardial contractility (maxVce) following total coronary perfusion with 20% Fluosol DA during total cardiopulmonary bypass in the in situ pig heart. They attributed the augmented contractility to the higher ionized calcium in Fluosol. In contrast, myocardial contractility was not augmented in the present sutdy. Glogar et al13) have successfully reduced the ischemic areas of the canine heart following occlusion of the LAD by bleeding to a hematocrit of 25% and infusing with an approximately equal volume of a fluorochemical preparation (Decamin 60).
Fluorochemicals tend to cause hypotension induced by anaphylactic vasodilatory effects, especially in dogs17),23) and this reduction in systemic blood pressure may reduce myocardial oxygen demand, though this possibility is not applicable in the present study because all experiments were initiated after desensitizing each animal to the perfluorochemical and no hypotension was observed during fluorochemical coronary infusion. Increased O2 delivery to the ischemie zones may occur as a result of enhanced diffusion of O2 from perfluorochemicals into ischemic tissue, perhaps because the size of the perfluorochemical particles is only 1/70 that of erythrocytes or through a decreased affinity of the blood-perfluorochemical mixture for O2.8),12) Perfluorochemicals are possibly effective in lowering the elevation of osmotic pressure and viscosity which occur under anaerobic metabolism. 8) In the beating heart, the ischemic myocardium perfused with the perfluorochemical has to contract against the stretching effects of the adjacent myocardium normally perfused with coronary arterial blood. Therefore, restoration of almost normal contraction with segmental perfluorochemical coronary perfusion as shown in this study proves its substitutive effects for whole blood on myocardial function, although "supernormal" effects on the 
